The global Preimplantation Genetic Testing (PGT) market is on the rise, projected to reach US$ 1.65 billion by 2033, driven by advancements in IVF and rising demand for precision medicine.

‘North America leads the Preimplantation genetic testing market, holding over 36% of the global share in 2023, with rapid growth in Asia-Pacific. #fertilitymarket #PGT #medindia’

Preimplantation Genetic Testing is a vital procedure used during in 




As awareness of genetic diseases grows and infertility rates rise globally, the demand for these advanced fertility treatments has surged.
North America Leads the Way
North America remains the dominant player in the PGT market, accounting for over 36% of the total market share in 2023. This is largely due to the region’s strong healthcare infrastructure and the growing number of individuals seeking fertility treatments. However, other regions, especially Asia-Pacific, are seeing rapid growth, driven by improvements in healthcare access and rising awareness of genetic testing.Technological Advancements Driving Growth
The PGT market is benefiting from several key technological advancements. One of the major innovations is Next-Generation Sequencing (NGS), which provides high-accuracy genetic screening by rapidly sequencing large DNA volumes. Additionally, tools like CRISPR-based gene editing are enhancing genetic testing methods, providing more precise solutions for selecting healthy embryos.Artificial Intelligence (AI) is also playing a significant role in transforming the field. AI-driven algorithms are being used to analyze genetic data, helping clinicians choose embryos with the best chances of successful implantation. These AI tools are improving decision-making and boosting the overall success rates of fertility treatments.
Advertisement
While the growth of PGT brings hope to many families, it also raises ethical questions. The ability to select embryos based on genetic traits has sparked debates about potential genetic discrimination and inequality. Experts are calling for careful guidelines to ensure the technology is used responsibly.
Advertisement
Reference:
- Preimplantation Genetic Testing Market Reach US$ 1648.6 Million by 2033 - (https://media.market.us/preimplantation-genetic-testing-market-news/)
Source-Medindia